RFK Jr., Vaccine Safety, and Public Health: Experts Urge Focus on Safer Vaccines Amid Program Cuts and Research Gaps

#VaccineSafety #RobertFKennedyJr #COVIDVaccineInjuries #CDC #VAERS #HHS #PostVaccineSyndrome #Myocarditis #VaccineCompensation #VaccineInjuryResearch

A Missed Opportunity for Safer Vaccines

While U.S. Health and Human Services Secretary Robert F. Kennedy Jr. continues to raise concerns about vaccine risks, many public health experts say he’s failing to lead meaningful reforms that could actually make vaccines safer. Instead, Kennedy has cut vital research initiatives, dismissed experienced scientists, and elevated voices long rejected by the scientific community.

Vaccine safety experts are sounding the alarm that these moves undermine decades of progress and leave vaccine-injured individuals with nowhere to turn — even as millions rely on vaccines for protection against serious illnesses.

Real Vaccine Injuries, Real Research Needs

Take Brianne Dressen, a preschool teacher who experienced debilitating symptoms after receiving a COVID-19 vaccine in 2020. Despite support from NIH researchers early on, the program investigating her case was abruptly shut down. Dozens of others reporting similar post-vaccine syndromes were left without care, answers, or federal recognition.

The FDA later determined that Dressen’s most common symptom, small-fiber neuropathy, appeared less often in vaccinated people than unvaccinated ones. However, researchers and patient advocates say that doesn’t invalidate her experience or the broader need for robust vaccine safety surveillance.

Cutting Critical Programs While Raising Alarms

Under Kennedy’s leadership, key vaccine safety infrastructure is being dismantled:

• Peter Marks, head of the FDA’s vaccine division, was forced out in May.
• A large-scale NIH study on genetic predispositions to vaccine-induced myocarditis was shut down.
• The entire Advisory Committee on Immunization Practices (ACIP) was fired and replaced with less qualified members, some of whom question the validity of most vaccines.
• Funding for long-standing vaccine monitoring systems like VAERS and the Vaccine Safety Datalink is absent from the proposed 2026 HHS budget.

According to experts, Kennedy is replacing data-driven approaches with ideological agendas. A spokesperson for HHS even called the CDC’s surveillance systems “templates of regulatory malpractice” and pledged to create new systems — but offered no specifics.

Scientists Call for Stronger, Not Weaker, Safety Research

Public health experts argue that vaccine safety systems — while imperfect — are critical and need more investment, not less. Researchers have urged Kennedy to expand rather than dismantle programs that protect public trust.

“Spending money on vaccine safety isn’t admitting vaccines are unsafe,” said Y. Tony Yang, a health policy professor at George Washington University. “It’s showing a commitment to making them better.”

Dan Salmon of Johns Hopkins University added that the current $20 million annual budget for vaccine safety is “woefully inadequate” to monitor all U.S. vaccines.

Compensation System: Broken and Unfair

The Countermeasures Injury Compensation Program (CICP), created to support those injured by pandemic vaccines, has been widely criticized for being inaccessible and ineffective. Out of nearly 14,000 COVID vaccine-related claims, just 39 have been approved, and only five awards exceeded $10,000.

By contrast, the National Vaccine Injury Compensation Program (VICP) — established in 1988 — has paid out $4.8 billion for about 12,000 claims, mostly for childhood vaccines.

Experts say the federal government must transition COVID vaccine injuries into the VICP, which is more robust and equitable. “The longer you hang these people out to dry, the more public trust erodes,” said vaccine injury attorney Renée Gentry.

Dismissed and Ignored: Patients Left Without Support

Patients suffering long COVID-like symptoms after vaccination feel abandoned. Research projects that might explain their experiences — like those at Yale and NIH — remain underfunded or unpublished. Germany, by contrast, has reviewed nearly 1,000 post-vaccine syndrome cases, acknowledging potential patterns and supporting further investigation.

“There’s the crowd that wants mRNA vaccines banned — but that’s not the answer,” said Dressen, who now leads a patient support group that has raised over $1.2 million for medical care. “Vaccines aren’t going away. But they need to be safer.”

A Call for Independent Oversight

Some scientists suggest moving vaccine safety oversight out of HHS entirely. Inspired by models like the National Transportation Safety Board, such an independent agency could speed up research and improve transparency — critical to restoring public trust.

Although Kennedy reportedly supports the idea, critics fear his recent staffing and funding decisions signal a different direction: one that risks turning skepticism into institutional failure.

Genetic Clues Could Make Vaccines Safer — But Research Halted

Before it was canceled, an international vaccine safety consortium led by U.S. and Canadian scientists found seven genetic markers linked to increased myocarditis risk after mRNA COVID vaccines. The potential? A $6 genetic test that could identify vulnerable individuals in advance.

But the Trump administration, followed by Kennedy’s leadership, withdrew funding, effectively shutting down the study. Researchers say the move not only wastes millions in progress — it delays life-saving discoveries.

The Bottom Line: Vaccine Safety Must Evolve

The U.S. vaccine safety system has had real successes: it removed a dangerous rotavirus vaccine in 1999, flagged AstraZeneca’s and J&J’s COVID vaccines, and helped detect myocarditis risk in young men.

But vaccine science must evolve with new data and emerging challenges. Cutting funding, firing experts, and promoting outdated theories doesn’t make vaccines safer — it makes the system weaker.

If Robert F. Kennedy Jr. truly wants to protect public health, experts say, he must move beyond rhetoric and invest in evidence-based solutions.